Furthermore, we detected higher 64Cu-CD4-Nb1 uptake in the spleen and tumor-draining and contralateral lymph nodes of PyMT-bearing ICI-treated hCD4-KI mice when compared to untreated PyMT- and B16F10-bearing hCD4-KI mice (Fig. 3, A to C, and fig. This evidence concerns the gene CD4 and neoplasm.